Skip to main content
. 2016 Jan 19;34(7):747–755. doi: 10.1200/JCO.2015.62.6846

Fig A1.

Fig A1.

Association of CD33 levels and GO response by treatment arm (GO v No-GO) and consolidation therapy (HSCT v chemotherapy) for patients with (A) low (Q1) CD33 expression and (B) higher (Q2to Q4) CD33 expression. Chemo, chemotherapy; GO, gemtuzumab ozogamicin; HSCT, hematopoietic stem cell transplantation; Q, quartile.